tranScrip strengthens regulatory leadership with appointment of Roz Sutton as Head of Regulatory

tranScrip is delighted to announce the promotion of Roz Sutton to Head of Regulatory, responsible for leading our Regulatory Business Unit. This appointment reflects our continued investment in developing our expert-led leadership across key functions and our commitment to delivering strategic regulatory solutions for clients worldwide.

Roz brings over 20 years of experience in global Regulatory Affairs, including senior roles at Roche and GSK, as well as consultancy experience at DLRC. Since joining tranScrip, she has led numerous complex programmes across a wide range of therapeutic areas, playing a pivotal role in expanding and evolving our regulatory capabilities to meet the changing needs of the pharmaceutical and biotech sectors.

Mark Corbett, Chief Executive Officer at tranScrip, said: “Roz’s deep regulatory expertise and client-centred approach make her exceptionally well-placed to lead this vital area of our business. As we continue to grow, strengthening leadership across all disciplines ensures we remain at the forefront of providing integrated drug development and commercialisation support.”

Roz commented: “I’m honoured to step into the Head of Regulatory Affairs role at tranScrip and feel privileged to work in partnership with our talented and dedicated team of experts. Building and implementing effective regulatory strategies is absolutely critical throughout the product development lifecycle.  I’m excited to support our clients in navigating the complex global regulatory landscape and in accelerating the delivery of innovative therapies to the patients who need them most.”

Roz’s appointment supports tranScrip’s broader strategy of structured growth and leadership across its core Business Units. Alongside Commercialisation and Clinical/Medical, our Regulatory function is integral to delivering an end-to-end model for pharmaceutical development and commercial success.

About tranScrip

tranScrip is a highly specialist pharmaceutical consultancy providing strategic expertise, therapeutic experience and operational excellence across the entire product lifecycle, from TRANslation to preSCRIPtion. We enable our clients to maximise the value of their products for the benefit of patients worldwide.